Immunovant Inc. (IMVT)
Market Open
16 Dec, 19:58
NASDAQ (NGS) NASDAQ (NGS) Primary $
26. 55
+0.55
+2.13%
$
4.15B Market Cap
- P/E Ratio
0% Div Yield
1,301,885 Volume
-1.77 Eps
$ 26
Previous Close Day Range
25.69 26.68
Year Range
12.72 28.08
Want to track IMVT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 50 days
Why Is Immunovant (IMVT) Up 13.8% Since Last Earnings Report?
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock?
Zacks | 1 year ago
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Zacks | 1 year ago
Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
Biohaven stock crashed Wednesday after the company's experimental protein-degrading drug lagged investor expectations.
Investors | 1 year ago
